Shares of Pacira Pharmaceuticals (PCRX) are soaring 5.35% in intraday trading on Friday, following news that activist investor Doma Perpetual Capital Management has taken a significant stake in the company. The stock surge comes as investors react positively to the potential for strategic changes at the pharmaceutical firm.

According to a regulatory filing, Pedro Escudero's Doma Perpetual Capital Management has disclosed a 5.7% stake in Pacira, representing over 2.69 million shares. The activist investor's involvement has sparked interest among market participants, as Doma Perpetual is reportedly seeking to influence the company's direction.

This development could have significant implications for Pacira Pharmaceuticals. Activist investors often push for changes in corporate strategy, management, or structure to unlock shareholder value. As the market digests this news, investors will be closely watching for any announcements regarding potential strategic shifts or discussions between Pacira's management and Doma Perpetual Capital Management.